5th Annual Personalized Medicine Conference

The emergence of personalized medicine is driving changes in business models, business strategies, IP, technologies for clinical testing, clinical research paradigms, regulation, and medical practice. Optimizing value creation in personalized medicine will require an in-depth and accurate understanding of the drivers in these areas and their dynamics. Key concepts relevant to developing more robust innovation strategies for PM include: the need for a fuller understanding of economic dependences of treatment and diagnostic markets, the importance of investments in aligning test and treatment development, and the extent to which partnering strategies can strengthen or weaken investments. Several approaches have been developed for studying innovation value chains, such as the The Analysis of Life Science Innovation Systems (ALSIS) model.